Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Toloxatone")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 39

  • Page / 2

Export

Selection :

  • and

ACTIVITE DE LA TOLOXATONE, D'ANTIDEPRESSEURS ET DE DIVERS AUTRES ANTAGONISTES DE LA RESERPINE SUR TROIS EPREUVES DE COMPORTEMENT CHEZ LA SOURIS TRAITEE PAR LE NIALAMIDEGOURET C; RAYNAUD G.1975; THERAPIE; FR.; DA. 1975; VOL. 30; NO 2; PP. 225-230; ABS. ANGL.; BIBL. 10REF.Article

Médicament nouveau pour le praticien: Humoryl* = A new drug: Humoryl®La Revue du praticien (Paris). 1986, Vol 36, Num 36, pp 2135-2136, issn 0035-2640Article

ETUDE CLINIQUE D'UN NOUVEL ANTIDEPRESSEUR: LE (69276).SUTTEL R; DUPLAN J.1975; INFORM. PSYCHIATR.; FR.; DA. 1975; VOL. 51; NO 5; PP. 599-601Article

METABOLIC FATE OF 3-(3-METHYLPHENYL)-5-HYDROXYMETHYL-2-OXAZOLIDINONE (TOLOXATONE) A NEW ANTIDEPRESSANT AGENT, IN MANMALNOE A; STROLIN BENEDETTI M.1979; XENOBIOTICA; GBR; DA. 1979; VOL. 9; NO 5; PP. 281-288; BIBL. 8 REF.Article

EFFECTS OF NEW ANTIDEPRESSANT (3-METHYL) 3-PHENYL 5-HYDROXY METHYL 2-OXAZOLIDINONE (TOLOXATONE) UPON 5-HYDROXYTRYPTAMINE PATHWAYS.KAN JP; PUJOL JF; MALNOE A et al.1977; EUROP. J. MEDICIN. CHEM.; FR.; DA. 1977; VOL. 12; NO 1; PP. 13-16; ABS. FR. ALLEM.; BIBL. 29 REF.Article

Effect of acute ethanol administration on toloxatone pharmacokinetics in rabbitsKALTENBACH, M. L; VISTELLE, R; HOIZEY, G et al.Alcoholism, clinical and experimental research. 1999, Vol 23, Num 5, pp 885-890, issn 0145-6008Conference Paper

Etude clinique d'Humoryl dans le traitement des états dépressifs. Synthèse de 628 observations = Clinical study of humoryl in the treatment of depression. Synthesis of 628 observationsDELAHAYE, C; DHONT, P.Gazette médicale de France (1969). 1986, pp 35-44, issn 0016-5557, 10 p., suppl. 26 bisSerial Issue

PHARMACOKINETICS OF TOLOXATONE IN MAN FOLLOWING INTRAVENOUS AND ORAL ADMINISTRATIONSSTROLIN BENEDETTI M; ROVEI V; DENCKER SJ et al.1982; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1982; VOL. 32; NO 3; PP. 276-280; ABS. GER; BIBL. 21 REF.Article

ETUDE NEUROELECTROPHYSIOLOGIQUE CHEZ LE CHAT D'UN NOUVEAU PSYCHOTROPE: LA TOLOXATONE.COSTON A; GOURET C; RAYNAUD G et al.1975; THERAPIE; FR.; DA. 1975; VOL. 30; NO 5; PP. 725-733; ABS. ANGL.; BIBL. 15 REF.Article

REDUCED ACCUMULATION IN BRAIN OF ORALLY INGESTED BETA -PHENETHYLAMINE AFTER INHIBITION OF TYPE A MONOAMINE OXIDASE IN THE RATKEANE PE; BENEDETTI MS.1981; J. PHARM. PHARMACOL.; ISSN 0022-3573; GBR; DA. 1981; VOL. 33; NO 12; PP. 800-802; BIBL. 20 REF.Article

EFFECT OF TOLOXATONE ON BEHAVIOUR OF PRIMATES.GIONO BARBER H; GIONO BARBER P; MILHAUD CL et al.1977; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1977; VOL. 27; NO 6; PP. 1188-1194; ABS. ALLEM.; BIBL. 21 REF.Article

Etudes «in vivo» et «in vitro» de plusieurs interactions avec les psychotropes = «in vivo» and «in vitro» Studies of interactions Between Psychotropic DrugsPochat-Perault, Marie-Christine; Cheymol, G.1995, 183 p.Thesis

Intoxication aiguë par la toloxatone : à propos de 122 observations = Toloxatone poisoning: report of 122 casesAZOYAN, P; GARNIER, R; BAUD, F. J et al.Thérapie (Paris). 1990, Vol 45, Num 2, pp 139-144, issn 0040-5957Article

Synthèses d'oxazolidinones, inhibiteurs de la monoamine oxydase de type A : relations structure-activité : vers la topographie du site d'actionGuiraudie, Jean-Marc; Le Goffic, François.1988, 179 p.Thesis

Gas―liquid chromatographic determination of toloxatone in human plasma: routine analysis of a wide range of drug concentrations using a nitrogen-selective detectorVAJTA, S; LEMOING, J. P; ROVEI, V et al.Journal of chromatography. 1983, Vol 274, pp 139-148, issn 0021-9673Article

Etude du profil des patients répondeurs à un IMAO réversible de référence: la toloxatone (Humoryl®) = Study of the profile of patients who respond to a standard reversible IMAO: toloxatone (Humoryl r)BORDET, P; DE LA GAROULLAYE, G.Comptes rendus de thérapeutique et de pharmacologie clinique. 1992, Num 101, pp 3-13, issn 0293-9908Article

Reversed-phase high-performance liquid chromatographic separation of 14C-labelled toloxatone and its metabolitesVAJTA, S; LE MOING, J. P; ROVEI, V et al.Journal of chromatography. 1984, Vol 311, Num 2, pp 329-337, issn 0021-9673Article

Simple high-performance liquid chromatographic method for the measurement of toloxatone in rabbit cerebrospinal fluid and plasmaVISTELLE, R; LAMIABLE, D; ZINZOU, M et al.Journal of chromatography. 1989, Vol 490, Num 2, pp 387-394, issn 0021-9673Article

A 2-amino-2-oxazoline derivative as an antidepressant in miceBOURIN, M; CREUZET, M. H; JARRY, C et al.Arzneimittel-Forschung. 1988, Vol 38, Num 5, pp 666-668, issn 0004-4172Article

Toloxatone pharmacokinetics in the plasma and cerebrospinal fluid of the rabbitVISTELLE, R; LAMIABLE, D; ZINSOU, M et al.Journal of pharmacy and pharmacology. 1992, Vol 44, Num 2, pp 124-126, issn 0022-3573Article

Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase-A inhibitor, and oral tyramine in healthy subjectsPROVOST, J.-C; FUNCK-BRENTANO, C; ROVEI, V et al.Clinical pharmacology and therapeutics. 1992, Vol 52, Num 4, pp 384-393, issn 0009-9236Article

MONOAMINE OXIDASE INHIBITION AND BRAIN AMINE METABOLISM AFTER ORAL TREATMENT WITH TOLOXATONE IN THE RATKEANE PE; KAN JP; SONTAG N et al.1979; J. PHARM. PHARMACOL.; GBR; DA. 1979; VOL. 31; NO 11; PP. 752-754; BIBL. 22 REF.Article

MONOAMINE OXIDASE INHIBITORY PROPERTIES OF 5-HYDROXYMETHYL-3-M-TOLYLOXAZOLIDIN-2-ONE (TOLOXATONE).KAN JP; MALONE A; BENEDETTI MS et al.1978; J. PHARM. PHARMACOL.; G.B.; DA. 1978; VOL. 30; NO 3; PP. 190-192; BIBL. 11 REF.Article

Minor and clinical non-significant interaction between toloxatone and amitriptylineVANDEL, S; BERTSCHY, G; PERAULT, M. C et al.European journal of clinical pharmacology. 1993, Vol 44, Num 1, pp 97-99, issn 0031-6970Article

Toloxatone, Parkinson et dopathérapie = Toloxatone, Parkinson's disease and dopatherapyCANTAGREL, A; DORDAIN, G; DOSTERT, P et al.Thérapie (Paris). 1986, Vol 41, Num 6, pp 493-497, issn 0040-5957Article

  • Page / 2